Table 2. Gender distribution of the study groups.
Groups | Male, n (%) | Female, n (%) | Total, n (%) |
HAART | 51 (51.0) | 49 (49.0) | 100 (100) |
HAART-naive | 48 (48.0) | 52 (52.0) | 100 (100) |
Control | 52 (52.0) | 48 (48.0) | 100 (100) |
Total | 151 (50.3) | 149 (49.7) | 300 (100) |
χ2 = 0.347, p = 0.841. HAART = highly active antiretroviral therapy.